Gait disturbances and muscle dysfunction in fibroblast growth factor 2 knockout mice

[1]  T. Doetschman,et al.  Ablation of low‐molecular‐weight FGF2 isoform accelerates murine osteoarthritis while loss of high‐molecular‐weight FGF2 isoforms offers protection , 2018, Journal of cellular physiology.

[2]  Liping Xiao,et al.  FGF23 Regulates Wnt/β-Catenin Signaling-Mediated Osteoarthritis in Mice Overexpressing High-Molecular-Weight FGF2. , 2018, Endocrinology.

[3]  M. Hurley,et al.  Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease , 2018, Journal of the Endocrine Society.

[4]  H. Häring,et al.  Fibroblast Growth Factor 21—Metabolic Role in Mice and Men , 2017, Endocrine reviews.

[5]  Michael P Phelps,et al.  Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis , 2016, The FEBS journal.

[6]  K. Avin,et al.  Reduced skeletal muscle function is associated with decreased fiber cross-sectional area in the Cy/+ rat model of progressive kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  Marco Paoloni,et al.  Clinical definition of sarcopenia. , 2014, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

[8]  N. Itoh.  FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases , 2014, Front. Endocrinol..

[9]  D. Kiel,et al.  Forum on bone and skeletal muscle interactions: Summary of the proceedings of an ASBMR workshop , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Douglas P Kiel,et al.  Bone and Skeletal Muscle: Neighbors With Close Ties , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  M. Stern,et al.  Bone-muscle interactions: ASBMR Topical Meeting, July 2012 , 2012 .

[12]  M. A. Basson,et al.  The aged niche disrupts muscle stem cell quiescence , 2012, Nature.

[13]  S. Ryu,et al.  Secretomics for skeletal muscle cells: a discovery of novel regulators? , 2012, Advances in biological regulation.

[14]  Sundeep Khosla,et al.  Forum on aging and skeletal health: Summary of the proceedings of an ASBMR workshop , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[16]  I. Amende,et al.  Gait Disturbances in Dystrophic Hamsters , 2011, Journal of biomedicine & biotechnology.

[17]  T. Doetschman,et al.  Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. , 2010, Bone.

[18]  P. Mcneil,et al.  Role of muscle-derived growth factors in bone formation. , 2010, Journal of musculoskeletal & neuronal interactions.

[19]  R. Burgess,et al.  Age, experience and genetic background influence treadmill walking in mice , 2009, Physiology & Behavior.

[20]  Yuichi Akasaki,et al.  FGF21 is an Akt‐regulated myokine , 2008, FEBS letters.

[21]  I. Conboy,et al.  Aging of signal transduction pathways, and pathology. , 2008, Experimental cell research.

[22]  J. Schertzer,et al.  Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness , 2008, Biogerontology.

[23]  F. Mehrbod,et al.  Molecular determinants of FGF‐21 activity—synergy and cross‐talk with PPARγ signaling , 2007, Journal of cellular physiology.

[24]  Anne-Sophie Armand,et al.  FGF6 in myogenesis. , 2006, Biochimica et biophysica acta.

[25]  E. Hoffman,et al.  Fgfr4 Is Required for Effective Muscle Regeneration in Vivo , 2006, Journal of Biological Chemistry.

[26]  D. Chinkes,et al.  Intramuscular and liver triglycerides are increased in the elderly. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  S. Heymsfield,et al.  Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. , 2004, The American journal of clinical nutrition.

[28]  T. Braun,et al.  Reduced Mobility of Fibroblast Growth Factor (FGF)-Deficient Myoblasts Might Contribute to Dystrophic Changes in the Musculature of FGF2/FGF6/mdx Triple-Mutant Mice , 2003, Molecular and Cellular Biology.

[29]  Z. Yablonka-Reuveni,et al.  Gene Expression Patterns of the Fibroblast Growth Factors and Their Receptors During Myogenesis of Rat Satellite Cells , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  D. Birnbaum,et al.  Skeletal muscle regeneration is not impaired in Fgf6 -/- mutant mice. , 2000, Biochemical and biophysical research communications.

[31]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[32]  B. Olwin,et al.  Loss of FGF receptor 1 signaling reduces skeletal muscle mass and disrupts myofiber organization in the developing limb. , 2000, Developmental biology.

[33]  S. Pawlowski,et al.  Fibroblast growth factor 2 control of vascular tone , 1998, Nature Medicine.

[34]  J. Lefaucheur,et al.  Basic fibroblast growth factor promotes in vivo muscle regeneration in murine muscular dystrophy , 1995, Neuroscience Letters.

[35]  J. Lefaucheur,et al.  Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor β1 or insulin-like growth factor I , 1995, Journal of Neuroimmunology.

[36]  S. Loring,et al.  Determinants of breathing frequency during walking. , 1990, Respiration physiology.